Insights

Publication | BRG

Geographic Variation in Medicare Part B Drug Spending

September 1, 2020

Medicare Part B provides access to a limited but important range of drugs and biologicals administered in a physician’s office or other outpatient settings. Policymakers have scrutinized the separate payments that Medicare makes for Part B drugs based on rising aggregate and per capita spending.

This report describes the geographic variation of Part B drug utilization across the United States using Core-based Statistical Areas (CBSAs) and examines potential drivers of these utilization differences.

Read the report.

Professionals

Related Professionals

Michael Sullivan

Managing Director

New York

Kevin Kohl

Associate Director

New York

Ruth E. Tabak

Associate Director

Washington, DC

Eva DuGoff

Associate Director

Washington, DC